![]() |
|
|


Julius Center for Patient Oriented Research, University Medical Center Utrecht, Utrecht, The Netherlands;
*
The Framingham Heart Study, Boston University School of Medicine, Boston, MA;
Department of Clinical Chemistry, University of Helsinki and Folkhälsan Research Center, Helsinki, Finland; and
**
Jean Mayer U.S. Department of Agriculture Human Nutrition Research Center on Aging at Tufts University, Boston, MA
5To whom correspondence should be addressed. E-mail: y.t.vanderschouw{at}jc.azu.nl.
| ABSTRACT |
|---|
|
|
|---|
KEY WORDS: phytoestrogens isoflavones coumestans lignans postmenopausal women
| INTRODUCTION |
|---|
|
|
|---|
Phytoestrogens are plant substances that are structurally and
functionally comparable to 17-ß-estradiol and that are capable of
producing estrogenic effects (Fig. 1
). Phytoestrogens bind to the estrogen receptor (ER) at low levels
compared with endogenous estrogen (1)
. By binding to the
receptor, phytoestrogens may exert both estrogenic and antiestrogenic
effects. It has been shown that in women consuming a
phytoestrogen-rich diet, sex hormone binding globulin
concentrations were increased (2
,3)
, hot flushes and
vaginal dryness were reduced and bone mineral density was increased
(4)
. Animal studies and trials in humans showed that
consuming soy, a food containing large amounts of phytoestrogens,
improves the plasma lipoprotein profile by decreasing total
cholesterol, LDL cholesterol and triglycerides (5
,6)
.
Ecological and migrant studies have suggested that phytoestrogens,
which are commonly consumed by Asian populations, play a role in
preventing cardiovascular disease and certain types of hormonally
responsive cancers (7
8
9)
. There are indications from
observational studies that phytoestrogens protect against breast cancer
(10
11
12)
and endometrial cancer (13)
.
Phytoestrogens can be classified in three groups, i.e., isoflavones,
coumestans and lignans. The major isoflavones are genistein, daidzein,
formononetin and biochanin A. Coumestrol is the most important
coumestan. The major lignans are enterolactone and enterodiol, which
are produced by colonic bacteria from their dietary precursors
matairesinol and secoisolariciresinol. The highest concentration of
isoflavones is found in soybeans, of coumestans in alfalfa and of
lignans in linseeds (8)
. Asian populations consume
2050 g of soy daily, which is their major source of
phytoestrogens, comparable to a daily intake of 2080 mg
phytoestrogens (7)
. Consumption of foods high in
phytoestrogens is uncommon in most Western countries. However, small
concentrations of phytoestrogens have been measured in several fruits
and vegetables (14
15
16
17)
, and also in coffee
(18)
, tea (18)
, beer (19)
and
wine (17)
, which are frequently consumed by Western
populations.
|
Our goal was to estimate the mean intake of dietary isoflavones,
coumestans and lignans in healthy Western postmenopausal women.
For this purpose, we assessed dietary phytoestrogen intake with
the Willett food-frequency questionnaire (FFQ) (21)
in
964 postmenopausal Caucasian women who participated in the Framingham
Offspring Study. All available literature on phytoestrogen
concentrations of food was used to extract data on phytoestrogen
contents of the food items present in the FFQ.
| SUBJECTS AND METHODS |
|---|
|
|
|---|
The Framingham Heart Study, an epidemiologic study of heart disease,
was established in Framingham, MA between 1948 and 1950 with a cohort
of 5209 men and women aged 3059 y (22)
. By 1971, the
original cohort included 1644 husband-wife pairs and 378
individuals who had developed cardiovascular disease. The offspring of
these subjects and their spouses were invited to participate, and 5135
of the 6838 eligible individuals participated in the first Framingham
Offspring Study examination (23)
. This study was approved
by the Human Investigations Review Committee at New England Medical
Center and by the Institutional Review Board for Human Research at
Boston University Medical Center. The offspring cohort has undergone
repeat examinations at
3- to 4-y cycles. Between January 1991 and
December 1994, 3799 members of the offspring cohort, of whom 1061
(27.9%) were postmenopausal women (at least 1 y after last
menses), participated in the fifth examination cycle. For this
analysis, we excluded women who did not fill in a FFQ, who left 12 or
more items blank on this questionnaire and those with an implausibly
high (
16.7 kJ) or low (<2.5 kJ) total energy intake
(n = 97). After these exclusions, 964
postmenopausal women remained for analysis.
Identifying food sources of phytoestrogens.
To locate published laboratory analysis data for the phytoestrogen
content of food items, we conducted a search of the medical (Medline)
and agricultural (Agricola) scientific literature and contacted several
experts in the field of phytoestrogens. We searched for data on
measurements of the phytoestrogens daidzein, genistein, formononetin,
biochanin A, coumestrol, matairesinol and secoisolariciresinol in
foods. We also searched the literature with the terms phytoestrogens,
plant estrogens, isoflavones, coumestans, isoflavones, lignans,
enterolactone and enterodiol. We expanded our database with unpublished
measured data (W. Mazur and H. Adlercreutz, Department of Clinical
Chemistry and Folkhälsan Research Center, University of Helsinki,
Finland) on lignan contents of some food items using an isotope
dilution gas chromatography/mass spectrometry method (24)
.
Food-frequency questionnaire.
The self-administered FFQ on dietary intake developed by Willett
and colleagues (21)
was used to assess usual food
consumption. This questionnaire lists 130 individual food items with
specified portion sizes; study participants were asked how often, on
average, they had consumed these food items during the previous year.
Nine responses were possible, ranging from "never or less than once
per month" to "more then six times per day." The questionnaire
also requested information about the use of specified vitamin and
mineral supplements, the brand of breakfast cereal and included
open-ended sections for information on foods and supplements not
specified on the questionnaire.
Scoring phytoestrogen intake.
Using the information from our review of the literature, we calculated
and assigned for each food item in the FFQ values for the isoflavones
daidzein, genistein, formononetin, biochanin A, coumestrol, and for the
lignans matairesinol and secoisolariciresinol, according to the
following protocol. All values found in the literature were converted
to mg per 100 g food. Values expressed on a dry weight basis were
converted to a wet weight basis either by using moisture content
provided by the author, by assuming commonly expected moisture content
for that particular food (25)
, or by using adjustments for
the method of preparation (26)
(Table 1
). When the specific phytoestrogen content was reported as "a trace"
or "traceable," the value of 0.00001 mg/100 g was assigned, which
was based on the sensitivity of the method used (24)
. When
more values were reported from the same or different original sources
in the literature we used the highest value to score the phytoestrogen
content of a food. If wet and dry weights were reported from different
original sources in the literature, we used the reported wet weight
value. If the questionnaire listed similar food items on the same line,
we used the phytoestrogen data for the food most commonly eaten. If
values for the most common food were unavailable, any value found on
one of the other food items in the line was used. When there was no
information available on the lignan precursors matairesinol and
secoisolaraisinol we estimated these values by using data on the
biologically active products enterolactone and enterodiol
(16)
. If we did not have any information about the
phytoestrogen content of a food item, we assigned a value using data of
a similar food item if available. If no data were available, we assumed
the value to be zero. We estimated the amount of the phytoestrogens in
breakfast cereals by using the fiber content of the cereal as a proxy
for the phytoestrogen content, using the Nutrition Data system of the
University of Minnesota [University of Minnesota, Nutrition Data
System (1998); http://www.ncc.umn.edu (March 2001; data not freely
accessible)]. The average phytoestrogen content of wheat bran and rye
bran was used to estimate the amount of phytoestrogen per gram fiber.
Each phytoestrogen content of a food item was then scored in seven
categories (Table 2
).Finally, we multiplied the score of each food item in milligrams by the
serving size of the food. This final phytoestrogen amount of each food
item was multiplied by the frequency of the consumption of that food
and then summed across foods to obtain the total individual intake of
each phytoestrogen.
|
|
|
Mean intake with standard deviation and median intake with interquartile range are presented for each phytoestrogen. The percentage of intake of isoflavones, coumestans and lignans from different food sources are presented.
| RESULTS |
|---|
|
|
|---|
The estimated daily median intake (25th75th percentiles) of the
isoflavone daidzein was 39 µg (2457 µg); of
genistein, 70 µg (28120 µg); of
formononetin, 31 µg (1344 µg); and of
biochanin A, 6 µg (211 µg) (Table 3
). Median total intake of isoflavones was 154 µg (99235
µg). The main sources of dietary isoflavones in this
population were beans and peas, tea and coffee, and nuts (Table 4
). The estimated daily intake of coumestans was 0.6 µg
(0.21.7 µg). The main source of coumestan was broccoli.
The estimated daily median intake of matairesinol was 19
µg (1228 µg) and of secoisolariciresinol,
560 µg (399778 µg). The median total intake
of lignans was 578 µg (416796 µg). The main
source of lignan in this population was "other fruits" (plums,
bananas, cantaloupe, watermelon, and apples or pears), breads, cereals,
rice and grain, and berries.
|
|
| DISCUSSION |
|---|
|
|
|---|
Before interpreting these data, some issues must be addressed. By using
a FFQ, we were able to quantify the average intake of dietary
phytoestrogens in the previous year. This is particularly important for
a study of dietary phytoestrogen intake because foods containing high
amounts of phytoestrogens are most likely to be consumed weekly or
monthly, not on a daily basis. Biochemical indicators are found in
urine and blood specimens (27
,28)
and can be used as a
measure of dietary phytoestrogen intake; however, these measurements
often represent only a short period of intake, i.e., several to 24 h before sampling (29
30
31)
. Biochemical indicators might
provide an index of intake and subsequent metabolism by the gut flora,
and therefore serve as a measure of bioavailability. Unfortunately the
usefulness of these biochemical indicators of dietary intake is
restricted; isoflavone excretion in the urine is substantial only in
Asian populations (7
,31)
and until now, only lignans can
be measured reliably in blood (32)
.
Dietary assessment methods such as 24-h dietary recall and food record
methods also represent a relatively short period of intake. The
underlying principle of the FFQ approach is that average long-term
diet is the conceptually important exposure rather than intake of a few
days (33)
.
Instead of using the exact measurements of phytoestrogen concentration
reported in the literature, we decided to score the highest literature
values into seven categories (Table 1)
. By doing so, we avoid the
suggestion of a degree of precision for which the reported data in the
literature are too limited and too preliminary. By using this method,
we decreased considerably the degree of misclassification of our
determinant of interest, phytoestrogen intake. Differences in the
phytoestrogen concentration of food items between types, brands or
different countries are not taken into account in this data set because
the number of measurements reported in the literature is limited. Most
measurements have been performed in one country (Finland), using only a
few types or brands. By using categories instead of exact amounts of
phytoestrogen content, these differences also do not bias our results
as long as they are within a 10-fold range of the data we used for our
classification. Our main concern is error in measurement of
phytoestrogen intake produced by missing data on some of the food items
consumed in the Western diet. We did have data on almost all vegetable
and fruit items in the FFQ, which are the food groups most likely to
contain phytoestrogens. The industrial use of soy flour could result in
the presence of phytoestrogens in food items such as donuts and white
bread; however, the processing of soy flour likely reduces the amounts
of phytoestrogens in these products.
The results indicate that the intake of lignans with the Western diet is much higher then the intake of isoflavones. Recent findings in the laboratory of one of the authors (H.A.) indicated that the presence of several enterolactone precursors is much more abundant than of the two (secoisolariciresinol and matairesinol) measured until now. When methods for the measurements of these precursors become available, the true lignan values will increase at least 10-fold in foods such as cereals. This means that the lignans are the most abundant phytoestrogen in the Western diet.
To our knowledge, this study is the first to determine daily food
intake of phytoestrogens in postmenopausal Western women. Until now,
only one research group also quantified the dietary intake of
phytoestrogens to address the association between dietary intake of
phytoestrogens and prostate cancer in a case-control study
(34
,35)
. This group used an adapted Block FFQ to measure
the intake of several phytoestrogens (36)
. The Block FFQ
was modified to include frequently consumed ethnic foods and foods that
were previously reported to be important sources of phytoestrogens.
Furthermore, adjustments were made for cooking and preparation, and the
original values as reported in the literature were used to determine
the intake. These values in general correspond to the values reported
in our study (Table 3)
because this research group was using the same
published sources. The median dietary intakes of genistein, daidzein,
secoisolariciresinol and matairesinol reported in the prostate cancer
study were comparable to the intakes in our study among postmenopausal
women. In our study, we used the 130-item Willett FFQ. No relevant
differences in ability to detect associations between nutrient intake
and disease have been reported for the Willett and Block FFQ
(37)
. Biochanin A and coumestrol intakes were higher and
formononetin intake was lower in the earlier study among men compared
with our study. This higher intake of some of phytoestrogens could be
explained in part by the addition of several specific food items (i.e.,
soy sauce, soy cheese, green tea) containing high amounts of
phytoestrogens to the Block FFQ used in the study among men.
Furthermore, a difference in the dietary pattern between men and women
is a possible explanation for the differences found. In this study,
mean (and sometimes median) values of phytoestrogen contents were used
instead of a scoring of the highest reported value in categories. This
could also explain in part the differences between the intake of
phytoestrogens in our study and the intake measured in the prostate
cancer study.
Estrogens act by binding to the ER, an intranuclear binding protein;
two types have now been identified, ER
and ERß. These receptors,
like all steroid hormone receptors, are transcription factors that
modify gene expression when they are activated (38)
.
Phytoestrogens bind to ER with low affinity compared with endogenous
estrogens and, depending on the tissue, may exert either estrogenic or
antiestrogenic effects. These effects are comparable to the effects of
Selective Estrogen Receptor Modulators such as Tamoxifen and Raloxifen.
With both estrogenic and antiestrogenic effects, it is possible to
reduce the risk of cardiovascular diseases as well as the risk of
breast cancer. The use of traditional hormone replacement therapy is
related to a lower cardiovascular risk but also with an increased risk
of breast cancer.
Antiestrogens are thought to exert their effect by decreasing the
concentration of cytoplasmic ER and by complexing with the receptor,
thus preventing biosynthetic processes associated with tissue
development (39)
. In postmenopausal women, endogenous
estrogen levels are very low and phytoestrogens are more likely to bind
to ER, leading to biological effects (20)
. Postmenopausal
women are at high risk of cardiovascular disease and breast cancer, and
effective preventive treatments could have a major effect on morbidity
and mortality.
The effects of phytoestrogens on different hormone-related diseases
have been studied primarily in Asian populations, who consume
2050
g soy/d, or in trials with soy supplements given to people consuming a
Western diet. For the former group, the high level of phytoestrogens
contained in soy is comparable to an intake of 2080 mg phytoestrogens
(7)
. The effects of daily intakes of low dietary
phytoestrogens have not yet been studied. To be able to study dietary
phytoestrogen intake more precisely in relation to disease risk and
incidence, a comprehensive and complete database of isoflavonoid,
coumestan and lignan contents of the most common foods in the Western
diet should be developed, including data on milk products and "fast
food"(possibly containing soymilk or soy flour), to increase the
comprehensiveness and accuracy of the nutrient database. The data that
have been collected for this study together with the existing database
on isoflavones can be used as a basis for an expanded database.
Availability of such data will enable longitudinal studies of the
health effects of dietary phytoestrogen intake in populations consuming
a Western diet.
This study shows that dietary intake of isoflavones, coumestans and lignans in healthy postmenopausal Caucasian women in the United States is low. In spite of the low intakes, recommendations for changes in the diet of postmenopausal women to increase dietary phytoestrogens may be premature before the health benefits of phytoestrogens are clearly demonstrated.
| ACKNOWLEDGMENTS |
|---|
| FOOTNOTES |
|---|
2 Supported by the Foundation "De Drie
Lichten," "De Gelderfonds" of the Dutch Heart Foundation and the
Foundation "Girard de Mielet van Coehoorn" of the University
Medical Center, Utrecht, in the Netherlands. Financial support for this
project was also provided by the U.S. Department of Agriculture, under
agreement No. 581950-9001. ![]()
3 Any opinions, findings, conclusion, or
recommendations expressed in this publication are those of the authors
and do not necessarily reflect the view of the U.S. Department of
Agriculture. ![]()
4 The authors have no financial relationship with
the supporting foundations. P.F.J. has a financial relationship with
the U.S. Department of Agriculture. The supporting foundations and the
U.S. Department of Agriculture did not control or influence the
decision to submit the final manuscript for publication. ![]()
Manuscript received October 24, 2000. Initial review completed December 15, 2000. Revision accepted March 8, 2001.
| REFERENCES |
|---|
|
|
|---|
1. Reinli K., Block G. Phytoestrogen content of foodsa compendium of literature values. Nutr. Cancer 1996;26:123-148[Medline]
2. Axelson M., Sjovall J., Gustafsson B. E., Setchell K. D. Origin of lignans in mammals and identification of a precursor from plants. Nature (Lond.) 1982;298:659-660[Medline]
3. Adlercreutz H., Mousavi Y., Loukovaara M., Hamalainen E. Lignans, isoflavones, sex hormone metabolism and breast cancer. Hochberg R. Naftolin F. eds. The New Biology of Steroid Hormones 1991 Raven Press New York. NY.
4. Brzezinski A., Adlercreutz H., Shaoul R. Short term effects of phytoestrogen rich diet on postmenopausal women. Menopause 1999;4:89-94
5. Wagner J. D., Cefalu W. T., Anthony M. S., Litwak K. N., Zhang L., Clarkson T. B. Dietary soy protein and estrogen replacement therapy improve cardiovascular risk factors and decrease aortic cholesteryl ester content in ovariectomized cynomolgus monkeys. Metabolism 1997;46:698-705[Medline]
6.
Anderson J. W., Johnstone B. M., Cook-Newell M. E. Meta-analysis of the effects of soy protein intake on serum lipids. N. Engl. J. Med. 1995;333:276-282
7.
Adlercreutz H., Honjo H., Higashi A., Fotsis T., Hamalainen E., Hasegawa T., Okada H. Urinary excretion of lignans and isoflavonoid phytoestrogens in Japanese men and women consuming a traditional Japanese diet. Am. J. Clin. Nutr. 1991;54:1093-1100
8. Adlercreutz H., Mazur W. Phyto-oestrogens and Western diseases. Ann. Med. 1997;29:95-120[Medline]
9. Adlercreutz H., Hamalainen E., Gorbach S., Goldin B. Dietary phyto-oestrogens and the menopause in Japan. Lancet 1992;339:1233[Medline]
10. Ingram D., Sanders K., Kolybaba M., Lopez D. Case-control study of phyto-oestrogens and breast cancer. Lancet 1997;350:990-994[Medline]
11. Lee H. P., Gourley L., Duffy S. W., Esteve J., Lee J., Day N. E. Dietary effects on breast-cancer risk in Singapore. Lancet 1991;337:1197-1200[Medline]
12. Adlercreutz H., Fotsis T., Heikkinen R., Dwyer J. T., Woods M., Goldin B. R., Gorbach S. L. Excretion of the lignans enterolactone and enterodiol and of equol in omnivorous and vegetarian postmenopausal women and in women with breast cancer. Lancet 1982;2:1295-1299[Medline]
13.
Goodman M. T., Wilkens L. R., Hankin J. H., Lyu L. C., Wu A. H., Kolonel L. N. Association of soy and fiber consumption with the risk of endometrial cancer. Am. J. Epidemiol. 1997;146:294-306
14. Mazur W., Adlercreutz H. Naturally occurring oestrogens in food. Pure Appl. Chem. 1998;70:1759-1776
15. Franke A. A., Custer L. J., Cerna C. M., Nasr A., Narala K. K. Quantitation of phytoestrogens in legumes by HPLC. J. Agric. Food Chem. 1994;42:1905-1913
16. Thompson L. U., Robb P., Serraino M., Cheung F. Mammalian lignan production from various foods. Nutr. Cancer 1991;16:43-52[Medline]
17. Mazur W. Phytoestrogens in food. Adlercreutz H. eds. Phytoestrogens. Baillieres Clinical Endocrinology and Metabolism 1999 Bailliere Tindall London, UK.
18. Mazur W. M., Wahala K., Rasku S., Salakka A., Hase T., Adlercreutz H. Lignan and isoflavonoid concentrations in tea and coffee. Br. J. Nutr. 1998;79:37-45[Medline]
19. Lapcik O., Hill M., Hampl R., Wahala K., Adlercreutz H. Identification of isoflavonoids in beer. Steroids 1998;63:14-20[Medline]
20.
Kuiper G. G., Lemmen J. G., Carlsson B., Corton J. C., Safe S. H., van der Saag P. T., van der Burg B., Gustafsson J. A. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 1998;139:4252-4263
21.
Rimm E. B., Giovannucci E. L., Stampfer M. J., Colditz G. A., Litin L. B., Willett W. C. Reproducibility and validity of an expanded self-administered semiquantitative food frequency questionnaire among male health professionals. Am. J. Epidemiol. 1992;135:1114-1126
22. Dawber T. R., Moore F. E., Mann G. V. Coronary heart disease in the Framingham study. Am. J. Public Health 1957;47(suppl):4-24
23. Feinleib M., Kannel W. B., Garrison R. J., McNamara P. M., Castelli W. P. The Framingham Offspring Study. Design and preliminary data. Prev. Med. 1975;4:518-525[Medline]
24. Mazur W., Fotsis T., Wahala K., Ojala S., Salakka A., Adlercreutz H. Isotope dilution gas chromatographic-mass spectrometric method for the determination of isoflavonoids, coumestrol, and lignans in food samples. Anal. Biochem. 1996;233:169-180[Medline]
25. United States Department of Agriculture Nutrient Data Laboratory 1999http://www.nal.usda.gov/fnic/cgi-bin/nut search.pl
26. Merrill A. L., Adams C. F., Fincher L. J. Procedures for calculating nutritive values of home-prepared foods: as used in griculture handbook no 8, composition of foodsraw, processed, prepared. 1966 USDA Washington, DC
27. Adlercreutz H., Fotsis T., Bannwart C., Wahala K., Makela T., Brunow G., Hase T. Determination of urinary lignans and phytoestrogen metabolites, potential antiestrogens and anticarcinogens, in urine of women on various habitual diets. J. Steroid Biochem. 1986;25:791-797[Medline]
28. Bingham S. A., Atkinson C., Liggins J., Bluck L., Coward A. Phyto-oestrogens: where are we now?. Br. J. Nutr 1998;79:393-406[Medline]
29. Hunter D. J. Biochemical indicators of dietary intake. Willett W. C eds. Nutritional Epidemiology 2nd ed. 1998:174-243 Oxford University Press New York, NY
30.
Karr S. C., Lampe J. W., Hutchins A. M., Slavin J. L. Urinary isoflavonoid excretion in humans is dose dependent at low to moderate levels of soy-protein consumption. Am. J. Clin. Nutr. 1997;66:46-51
31. Adlercreutz H., Fotsis T., Lampe J., Wahala K., Makela T., Brunow G., Hase T. Quantitative determination of lignans and isoflavonoids in plasma of omnivorous and vegetarian women by isotope dilution gas chromatography-mass spectrometry. Scand. J. Clin. Lab. Investig. Suppl. 1993;215:5-18[Medline]
32. Zeleniuch-Jacquotte A., Adlercreutz H., Akhmedkhanov A., Toniolo P. Reliability of serum measurements of lignans and isoflavonoid phytoestrogens over a two-year period. Cancer Epidemiol. Biomark. Prev. 1998;7:885-889[Abstract]
33. Willett W. C. Food frequency methods. Willett W. C. eds. Nutritional Epidemiology 2nd ed. 1998:74-100 Oxford University Press New York, NY
34. Pillow P. C., Duphorne C. M., Chang S., Contois J. H., Strom S. S., Spitz M. R., Hursting S. D. Development of a database for assessing dietary phytoestrogen intake. Nutr. Cancer 1999;33:3-19[Medline]
35. Strom S. S., Yamamura Y., Duphorne C. M., Spitz M. R., Babaian R. J., Pillow P. C., Hursting S. D. Phytoestrogen intake and prostate cancer: a case-control study using a new database. Nutr. Cancer 1999;33:20-25[Medline]
36. Block G., Hartman A. M., Naughton D. A reduced dietary questionnaire: development and validation. Epidemiology 1990;1:58-64[Medline]
37.
Caan B. J., Slattery M. L., Potter J., Quesenberry C.P.J., Coates A. O., Schaffer D. M. Comparison of the Block and the Willett self-administered semiquantitative food frequency questionnaires with an interviewer-administered dietary history. Am. J. Epidemiol. 1998;148:1137-1147
38.
Mendelsohn M. E., Karas R. H. The protective effects of estrogen on the cardiovascular system. N. Engl. J. Med. 1999;340:1801-1811
39. Brown M. Estrogen receptor molecular biology. Hematol. Oncol. Clin. N. Am. 1994;8:101-112[Medline]
40. USDA-Iowa State University Database on the Isoflavone Content of Foods 1998www.nal.usda.gov/fnic/foodcomp/Data/isofl/isoflav.html (May 1998)
41. Mazur W. M., Duke J. A., Wahala K., Rasku S., Adlercreutz H. Isoflavanoids and lignans in legumes: nutritional and health aspects in humans. J. Nutr. Biochem. 1998;9:193-200
This article has been cited by other articles:
![]() |
A. Pan, O. H. Franco, J. Ye, W. Demark-Wahnefried, X. Ye, Z. Yu, H. Li, and X. Lin Soy Protein Intake Has Sex-Specific Effects on the Risk of Metabolic Syndrome in Middle-Aged and Elderly Chinese J. Nutr., December 1, 2008; 138(12): 2413 - 2421. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. W. Xiao Health Effects of Soy Protein and Isoflavones in Humans J. Nutr., June 1, 2008; 138(6): 1244S - 1249S. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hedelin, M. Lof, M. Olsson, H. Adlercreutz, S. Sandin, and E. Weiderpass Dietary Phytoestrogens Are Not Associated with Risk of Overall Breast Cancer But Diets Rich in Coumestrol Are Inversely Associated with Risk of Estrogen Receptor and Progesterone Receptor Negative Breast Tumors in Swedish Women J. Nutr., May 1, 2008; 138(5): 938 - 945. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Si and D. Liu Genistein, a Soy Phytoestrogen, Upregulates the Expression of Human Endothelial Nitric Oxide Synthase and Lowers Blood Pressure in Spontaneously Hypertensive Rats J. Nutr., February 1, 2008; 138(2): 297 - 304. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Gardner, G. L. Brower, T. G. Voloshenyuk, and J. S. Janicki Cardioprotection in female rats subjected to chronic volume overload: synergistic interaction of estrogen and phytoestrogens Am J Physiol Heart Circ Physiol, January 1, 2008; 294(1): H198 - H204. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. N. Fink, S. E. Steck, M. S. Wolff, J. A. Britton, G. C. Kabat, M. M. Gaudet, P. E. Abrahamson, P. Bell, J. C. Schroeder, S. L. Teitelbaum, et al. Dietary Flavonoid Intake and Breast Cancer Survival among Women on Long Island Cancer Epidemiol. Biomarkers Prev., November 1, 2007; 16(11): 2285 - 2292. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A Grippo, K. Capps, B. Rougeau, and B. J Gurley Analysis of Flavonoid Phytoestrogens in Botanical and Ephedra-Containing Dietary Supplements Ann. Pharmacother., September 1, 2007; 41(9): 1375 - 1382. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. K. Chun, S. J. Chung, and W. O. Song Estimated Dietary Flavonoid Intake and Major Food Sources of U.S. Adults J. Nutr., May 1, 2007; 137(5): 1244 - 1252. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Touillaud, A. C. M. Thiebaut, A. Fournier, M. Niravong, M.-C. Boutron-Ruault, and F. Clavel-Chapelon Dietary Lignan Intake and Postmenopausal Breast Cancer Risk by Estrogen and Progesterone Receptor Status J Natl Cancer Inst, March 21, 2007; 99(6): 475 - 486. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Steiner, W. H.M. Peters, E. P. Gallagher, P. Magee, I. Rowland, and B. L. Pool-Zobel Genistein protects human mammary epithelial cells from benzo(a)pyrene-7,8-dihydrodiol-9,10-epoxide and 4-hydroxy-2-nonenal genotoxicity by modulating the glutathione/glutathione S-transferase system Carcinogenesis, March 1, 2007; 28(3): 738 - 748. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Erdman Jr., D. Balentine, L. Arab, G. Beecher, J. T. Dwyer, J. Folts, J. Harnly, P. Hollman, C. L. Keen, G. Mazza, et al. Flavonoids and Heart Health: Proceedings of the ILSI North America Flavonoids Workshop, May 31-June 1, 2005, Washington, DC J. Nutr., March 1, 2007; 137(3): 718S - 737S. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. N. Fink, S. E. Steck, M. S. Wolff, J. A. Britton, G. C. Kabat, J. C. Schroeder, S. L. Teitelbaum, A. I. Neugut, and M. D. Gammon Dietary Flavonoid Intake and Breast Cancer Risk among Women on Long Island Am. J. Epidemiol., March 1, 2007; 165(5): 514 - 523. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. French, L. U. Thompson, and G. A. Hawker Validation of a Phytoestrogen Food Frequency Questionnaire with Urinary Concentrations of Isoflavones and Lignan Metabolites in Premenopausal Women J. Am. Coll. Nutr., February 1, 2007; 26(1): 76 - 82. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Touillaud, A. C.M. Thiebaut, M. Niravong, M.-C. Boutron-Ruault, and F. Clavel-Chapelon No Association between Dietary Phytoestrogens and Risk of Premenopausal Breast Cancer in a French Cohort Study Cancer Epidemiol. Biomarkers Prev., December 1, 2006; 15(12): 2574 - 2576. [Full Text] [PDF] |
||||
![]() |
M. Cotterchio, B. A. Boucher, M. Manno, S. Gallinger, A. Okey, and P. Harper Dietary Phytoestrogen Intake Is Associated with Reduced Colorectal Cancer Risk J. Nutr., December 1, 2006; 136(12): 3046 - 3053. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. C. H. Hollman, I. E. J. Milder, I. C. W. Arts, E. J. M. Feskens, H. B. Bueno de Mesquita, and D. Kromhout Phytoestrogens and Risk of Lung Cancer JAMA, February 15, 2006; 295(7): 755 - 755. [Full Text] [PDF] |
||||
![]() |
B. L McVeigh, B. L Dillingham, J. W Lampe, and A. M Duncan Effect of soy protein varying in isoflavone content on serum lipids in healthy young men Am. J. Clinical Nutrition, February 1, 2006; 83(2): 244 - 251. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Reimann, J. Dierkes, A. Carlsohn, D. Talbot, M. Ferrari, J. Hallund, W. L. Hall, K. Vafeiadou, U. Huebner, F. Branca, et al. Consumption of Soy Isoflavones Does Not Affect Plasma Total Homocysteine or Asymmetric Dimethylarginine Concentrations in Healthy Postmenopausal Women J. Nutr., January 1, 2006; 136(1): 100 - 105. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B. Schabath, L. M. Hernandez, X. Wu, P. C. Pillow, and M. R. Spitz Dietary Phytoestrogens and Lung Cancer Risk JAMA, September 28, 2005; 294(12): 1493 - 1504. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Harris, E. Besselink, S. M. Henning, V. L. W. Go, and D. Heber Phytoestrogens Induce Differential Estrogen Receptor Alpha- or Beta-Mediated Responses in Transfected Breast Cancer Cells Experimental Biology and Medicine, September 1, 2005; 230(8): 558 - 568. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. H. Franco, H. Burger, C. E. I. Lebrun, P. H. M. Peeters, S. W. J. Lamberts, D. E. Grobbee, and Y. T. Van Der Schouw Higher Dietary Intake of Lignans Is Associated with Better Cognitive Performance in Postmenopausal Women J. Nutr., May 1, 2005; 135(5): 1190 - 1195. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. E. J. Milder, E. J. M. Feskens, I. C. W. Arts, H. B. B. de Mesquita, P. C. H. Hollman, and D. Kromhout Intake of the Plant Lignans Secoisolariciresinol, Matairesinol, Lariciresinol, and Pinoresinol in Dutch Men and Women J. Nutr., May 1, 2005; 135(5): 1202 - 1207. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Atkinson, C. L. Frankenfeld, and J. W. Lampe Gut Bacterial Metabolism of the Soy Isoflavone Daidzein: Exploring the Relevance to Human Health Experimental Biology and Medicine, March 1, 2005; 230(3): 155 - 170. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. T. van der Schouw, L. Sampson, W. C. Willett, and E. B. Rimm The Usual Intake of Lignans but Not That of Isoflavones May Be Related to Cardiovascular Risk Factors in U.S. Men J. Nutr., February 1, 2005; 135(2): 260 - 266. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. T. van der Schouw, S. Kreijkamp-Kaspers, P. H.M. Peeters, L. Keinan-Boker, E. B. Rimm, and D. E. Grobbee Prospective Study on Usual Dietary Phytoestrogen Intake and Cardiovascular Disease Risk in Western Women Circulation, February 1, 2005; 111(4): 465 - 471. [Abstract] [Full Text] [PDF] |